Abnormal axial diffusivity in the deep gray nuclei and dorsal brain stem in infantile spasm treated with vigabatrin.
We evaluated the DTI changes in the deep gray nuclei and dorsal brain stem, which demonstrated abnormal T2 and/or diffusion signal intensity, in 6 patients with infantile spasm treated with vigabatrin compared with 6 age-matched controls. Regions of interest were placed in the globi pallidi, thalami, and dorsal brain stem; FA, trace, D(‖), and D(⊥) were measured. Patients on vigabatrin had significantly lower FA in both globi pallidi (P = .01) and the dorsal brain stem (P < .01), significantly lower trace in both globi pallidi (P = .01) and the thalami (P = .02 and .01 for right and left, respectively), and significantly lower D(‖) in both globi pallidi (P ≤ .01), the thalami (P < .01), and the dorsal brain stem (P = .03). There were no significant differences in D(⊥) of the globi pallidi, thalami, or dorsal brain stem in patients compared with controls. The findings suggest that axonal changes play a greater role in the observed abnormal signal intensity, with lesser contribution from myelin changes.
Simao
G N
GN
Department of Diagnostic Imaging, Hospital for Sick Children, Toronto, Ontario, Canada.
Zarei Mahmoodabadi
S
S
Snead
O C
OC
Go
C
C
Widjaja
E
E
D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D001933:Brain Stem / Q000187:drug effects* / Q000473:pathology*; D020833:Diffuse Axonal Injury / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007223:Infant; D008279:Magnetic Resonance Imaging; D008297:Male; D013036:Spasms, Infantile / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome; D020888:Vigabatrin / Q000009:adverse effects* / Q000627:therapeutic use*
D000927:Anticonvulsants; D020888:Vigabatrin
Exp Neurol. 1997 Apr;144(2):400-5
9168839
Neuroimage. 2004 Aug;22(4):1767-74
15275932
Br J Clin Pharmacol. 1989;27 Suppl 1:47S-52S
2757909
Epilepsy Res. 1994 May;18(1):57-66
8088257
J Child Neurol. 2009 Mar;24(3):305-15
19258289
Epilepsia. 1995 Jan;36(1):93-100
8001516
Epilepsia. 2010 Jul;51(7):1297-304
20384718
J Child Neurol. 2009 Dec;24(12):1543-6
19773459
Epilepsia. 2009 Feb;50(2):195-205
19054414
Magn Reson Med. 1996 Oct;36(4):627-31
8892217
Epilepsia. 2009 Feb;50(2):184-94
18783433
Neuroimage. 2003 Nov;20(3):1714-22
14642481
J Magn Reson B. 1996 Jun;111(3):209-19
8661285
Epilepsia. 2009 Feb;50(2):163-73
19230067
Epilepsia. 2000 Jun;41(6):655-65
10840396
Neuroimage. 2002 Nov;17(3):1429-36
12414282
Toxicol Pathol. 1987;15(2):143-8
3616399